Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals submits press release

09 Apr 2026 Evaluate

Glenmark Pharmaceuticals has submitted press release stating that Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..